No Data
No Data
Assertio to Participate in the IAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
Assertio Holdings Is Maintained at Buy by HC Wainwright & Co.
Assertio Holdings Analyst Ratings
Express News | Assertio Holdings, Inc. : H.c. Wainwright Cuts Target Price to $3.5 From $4
New Analyst Forecast: $ASRT Given $1.75 Price Target
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.